Cross-sectional study to establish the relation between myocardial, skin and serum Advanced Glycation End-products (AGEs) levels

Cross-sectional study to establish the relation between myocardial, skin and serum Advanced Glycation End-products (AGEs) levels - Myocardial AGEs: a validation study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON32513

Enrollment

Registered

2010-06-07

Start date

2010-01-28

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patiënten die op de wachtlijst staan voor CABG en hartklep operaties etiology decompensatio cordis etiology heart failure

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - significant coronary artery disease requiring CABG and/or severe valvular disease requiring valve surgery.

Exclusion criteria

Exclusion criteria: - Fitzpatrick type V and VI skin colour - Sustained/accepted atrial fibrillation - Active pericarditis, endocarditis or myocarditis - Severe myocardial fibrosis and/or hypertrophy - history of heart transplantation

Design outcomes

Primary

Measure	Time frame
The primary end-point of the study will be the relation between myocardial, skin and serum AGE levels.	—

Secondary

Measure	Time frame
The secundary study parameter will be the quantitative measurement of myocardial AGE-levels.	—

Countries

Netherlands

Outcome results